Germline and somatic RUNX1 variants in a pediatric bone marrow failure cohort

Affiliations

¹ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
³ Department of Pediatrics, Hiroshima University Graduate School of Biomedical & Health Sciences, Hiroshima, Japan.
⁴ Department of Pediatric Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan.
⁵ Division of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Okinawa, Japan.
⁶ Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
⁷ Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.
⁸ Department of Pediatrics, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
⁹ Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
¹⁰ Department of Pathology, Shizuoka Children's Hospital, Shizuoka, Japan.
¹¹ Department of Pathology, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
¹² Department of Virology, Nagoya City University Graduate School of Medical Science and Medical School, Nagoya, Japan.

Free article

Ayako Yamamori et al. Am J Hematol. 2023 May.

Free article

. 2023 May;98(5):E102-E105.

doi: 10.1002/ajh.26874. Epub 2023 Feb 20.

¹ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
³ Department of Pediatrics, Hiroshima University Graduate School of Biomedical & Health Sciences, Hiroshima, Japan.
⁴ Department of Pediatric Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan.
⁵ Division of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Okinawa, Japan.
⁶ Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
⁷ Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.
⁸ Department of Pediatrics, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
⁹ Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
¹⁰ Department of Pathology, Shizuoka Children's Hospital, Shizuoka, Japan.
¹¹ Department of Pathology, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
¹² Department of Virology, Nagoya City University Graduate School of Medical Science and Medical School, Nagoya, Japan.

No abstract available

References

1. Homan CC, King-Smith SL, Lawrence DM, et al. The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy. Haematologica. 2021;106(11):3004-3007.
1. Luo X, Feurstein S, Mohan S, et al. ClinGen myeloid malignancy variant curation expert panel recommendations for germline RUNX1 variants. Blood Adv. 2019;3(20):2962-2979.
1. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703-1719.
1. Bagla S, Regling KA, Wakeling EN, et al. Distinctive phenotypes in two children with novel RUNX1 mutations - one with myeloid malignancy and increased fetal hemoglobin. Pediatr Hematol Oncol. 2021;38(1):65-79.
1. Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev. 2008;22(4):173-186.